Effects of Postoperative Video-assisted Early Mobilization on Recovery Outcomes

This randomized controlled trial aims to evaluate the effects of video-assisted early mobilization education on postoperative recovery in patients undergoing laparoscopic cholecystectomy. As part of the intervention, structured and professionally produced educational videos will be used to explain the physiological benefits of early mobilization in the preoperative period and to demonstrate step-by-step mobilization techniques in the postoperative period. Patients in the intervention group will receive video-assisted mobilization education in addition to standard postoperative care, while patients in the control group will receive standard care alone. Physical activity levels will be objectively monitored using wearable activity tracking devices during the first 24 hours after surgery. The study will assess the effects of video-assisted early mobilization education on postoperative physiological stress response, pain, nausea and vomiting, blood glucose levels, mobilization performance, gastrointestinal recovery, length of hospital stay, and patient satisfaction. In addition, postoperative complications, emergency department visits, and hospital readmissions within 30-days after surgery will be evaluated as exploratory outcomes.

Inclusion Criteria: * Adults aged 18 to 65 years. * Scheduled for elective laparoscopic cholecystectomy. * Classified as ASA I or ASA II according to the American Society of Anesthesiologists Physical Status Classification. * Ability to read and understand Turkish. * Adequate cognitive capacity to understand video education and operate the wearable activity tracker. * Willingness to participate and signing the informed consent form Exclusion Criteria: * Chronic pain syndrome or severe chronic orthopedic/rheumatologic pain conditions. * Pre-existing mobility limitations. * Endocrine or metabolic diseases affecting cortisol or glucose (e.g., diabetes, thyroid disorders, Addison's disease, Cushing's syndrome). * Use of medications affecting the HPA axis (e.g., systemic corticosteroids, chronic opioids, high-dose benzodiazepines). * Diagnosed severe psychiatric or cognitive disorders (e.g., dementia, major depression). * Skin allergies or medical device contraindications preventing use of the activity tracker. * Conversion to open surgery or major intraoperative complications.